Stem Cell Medicinal and Research Act of 2016
Author: Alexander J. Maxwell (SLP)
§1 – Definitions:
Stem Cell: An undifferentiated cell of a multicellular organism that is capable of giving rise to indefinitely more cells of the same type, and from which certain other kinds of cell arise by differentiation | Cells with the ability to divide for indefinite periods in culture and to give rise to specialized cells.
DNA: Deoxyribonucleic acid, a chemical found primarily in the nucleus of cells. DNA carries the instructions or blueprint for making all the structures and materials the body needs to function. DNA consists of both genes and non-gene DNA in between the genes.
Embryonic Stem Cell: Primitive (undifferentiated) cells derived from a 5-day preimplantation embryo that are capable of dividing without differentiating for a prolonged period in culture, and are known to develop into cells and tissues of the three primary germ layers.
Somatic (Adult) Stem Cell: A relatively rare undifferentiated cell found in many organs and differentiated tissues with a limited capacity for both self renewal (in the laboratory) and differentiation. Such cells vary in their differentiation capacity, but it is usually limited to cell types in the organ of origin.
Induced Pluripotent Stem Cells (iPSC): Somatic (adult) cells reprogrammed to enter an embryonic stem cell–like state by being forced to express factors important for maintaining the "stemness" of embryonic stem cells (ESCs). Mouse iPSCs were first reported in 2006 (Takahashi and Yamanaka), and human iPSCs were first reported in late 2007 (Takahashi et al. and Yu et al.). Mouse iPSCs demonstrate important characteristics of pluripotent stem cells, including the expression of stem cell markers, the formation of tumors containing cells from all three germ layers, and the ability to contribute to many different tissues when injected into mouse embryos at a very early stage in development. Human iPSCs also express stem cell markers and are capable of generating cells characteristic of all three germ layers.
§2 – Government Permittance:
The following are to be permitted under federal law, and may only be overturned by the decision of a high judicial body (i.e: Supreme Court):
a. The usage of all forms of stem cells in the fields of, but not limited to: medicine, biology, biochemistry, biochemical engineering, nanotechnology, in vitro fertilization, microbiology and epidemiology.
b. The ability for both the public and private sector to use all forms of stem cells at their discretion, primarily for the fields mentioned in "a", without the threat of legal and criminal action taken against them.
c. Government subsidies of stem cell research.
d. The genetic manipulation of both living and deceased stem cells of every variety.
§3 – Government Entities:
The following entities shall be constituted under this Act:
a. The Senate Stem Cell Oversight Committee (oversees the proliferation of stem cell research in the public sector, along with the portion of the private sector invested in stem cell research whom receive government subsidies).
b. The Corporate Stem Cell Oversight Subcommittee-(Subordinate to the SSCOC; oversees the proliferation of stem cell research in the portion of the private sector whom does not receive government subsidies, and is not affiliated with any government entity).